Literature DB >> 11520159

Malignant struma ovarii with thyrotoxicosis.

K Matsuda1, T Maehama, K Kanazawa.   

Abstract

BACKGROUND: Malignant struma ovarii is seldom diagnosed preoperatively due to the rarity of the disease itself and the even rarer complications of thyrotoxicosis. CASE: A 48-year-old woman presented with symptoms of hyperthyroidism and a pelvic tumor raising the possibility of ovarian malignancy. Hormonal findings revealed increased thyroid function, but the thyroid gland was normal in size and texture. Thus, she was diagnosed preoperatively as having a hormone-producing malignant struma ovarii. At surgery, a FIGO stage Ia ovarian papillary adenocarcinoma of the thyroid was found. An immunohistochemical tumor stain for thyroglobulin was positive and the ovarian venous thyroglobulin level was extremely high. Findings of hyperthyroidism disappeared over several weeks.
CONCLUSION: Malignant struma ovarii can be diagnosed preoperatively. Complications of thyrotoxicosis should be kept in mind when evaluating an ovarian tumor. Copyright 2001 Academic Press.

Entities:  

Mesh:

Year:  2001        PMID: 11520159     DOI: 10.1006/gyno.2001.6315

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  19 in total

1.  Predominant Brenner tumor combined with struma ovarii containing a papillary microcarcinoma associated with benign peritoneal strumosis: report of a case and histologic features.

Authors:  Simone Sibio; Francesco Borrini; Paolo Sammartino; Fabio Accarpio; Daniele Biacchi; Giuliana Caprio; Franco Iafrate; Anna Maria Baccheschi; Tommaso Cornali; Angelo Di Giorgio
Journal:  Endocr Pathol       Date:  2010-09       Impact factor: 3.943

2.  An Unusual Case of Malignant Struma Ovarii Causing Thyrotoxicosis.

Authors:  Elli Anagnostou; Antonios Polymeris; Georgios Morphopoulos; Alexios Travlos; Vassiliki Sarantopoulou; Irini Papaspyrou
Journal:  Eur Thyroid J       Date:  2016-09-08

3.  Struma ovarii accompanied by mature cystic teratoma of the other ovary: A case report and literature review.

Authors:  Peng-Fei Qiao; Yang Gao; Guang-Ming Niu
Journal:  Oncol Lett       Date:  2015-03-11       Impact factor: 2.967

4.  Struma ovarii in breast cancer.

Authors:  Francesco Frattini; Francesca Rovera; Stefano Rausei; Gianlorenzo Dionigi; Luigi Boni; Antonio Biondi; Renzo Dionigi
Journal:  Updates Surg       Date:  2011-04-20

Review 5.  Expression of benign and malignant thyroid tissue in ovarian teratomas and the importance of multimodal management as illustrated by a BRAF-positive follicular variant of papillary thyroid cancer.

Authors:  Erin F Wolff; Marybeth Hughes; Maria J Merino; James C Reynolds; Jeremy L Davis; Craig S Cochran; Francesco S Celi
Journal:  Thyroid       Date:  2010-09       Impact factor: 6.568

6.  A case of papillary thyroid carcinoma in struma ovarii and review of the literature.

Authors:  W D Salman; Mayuri Singh; Z Twaij
Journal:  Patholog Res Int       Date:  2010-08-02

7.  Ovarian teratoma mimicking metastasis on I-131 scan : a case report.

Authors:  Sohee Yoon; In Soo Hong
Journal:  Nucl Med Mol Imaging       Date:  2012-09-15

8.  Malignant struma ovarii: a case report and review of the literature.

Authors:  M L Mattucci; A Dellera; A Guerriero; F Barbieri; L Minnelli; L Furlani
Journal:  J Endocrinol Invest       Date:  2007-06       Impact factor: 4.256

9.  Parvovirus b19 persistence in abnormal thyroid tissue of a mature cystic ovarian teratoma: a case report.

Authors:  Laura A Adamson-Small; Larry J Fowler; Jacqueline A Hobbs
Journal:  Endocr Pathol       Date:  2014-09       Impact factor: 3.943

10.  Unilateral follicular variant of papillary thyroid carcinoma with unique KRAS mutation in struma ovarii in bilateral ovarian teratoma: a rare case report.

Authors:  Boban Stanojevic; Radan Dzodic; Vladimir Saenko; Zorka Milovanovic; Vesna Krstevski; Petar Radlovic; Marko Buta; Bozidar Rulic; Lidija Todorovic; Bogomir Dimitrijevic; Shunichi Yamashita
Journal:  BMC Cancer       Date:  2012-06-08       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.